a2 Milk Company Ltd. Report issue

For profit Phase 4
Founded: Auckland New Zealand (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2014
NCT02406469
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

a2 Milk Company Ltd.

Active Ingredients

Drugs in Phase 4 Trials (2)

cow milk (4 trials)

human milk (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Inflammation (Phase 4)

Lactose Intolerance (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 2